<DOC>
	<DOCNO>NCT01134536</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic ( PK ) profile ; safety tolerability single dose tapentadol oral solution ( OS ) 1 mg/kg child adolescent age 6 less 18 year acute , moderate severe postsurgical pain .</brief_summary>
	<brief_title>Pharmacokinetics Safety Study Tapentadol Postsurgical Pain Children Adolescents</brief_title>
	<detailed_description>This multicenter , single-arm , open-label ( people involve know identity intervention ) , single-dose study evaluate pharmacokinetic ( PK ) profile ( drug absorb body , distribute within body remove body time ) , safety tolerability tapentadol 1 mg/kg oral solution ( OS ) child age 6 less 18 year schedule surgical procedure routinely produce acute , moderate severe postsurgical pain . A screening phase , per standard care exceed 30 day , include preoperative evaluation , surgical procedure immediate post recovery , follow open-label treatment phase end-of-study assessment . Study drug administration take place surgery complete , patient alert , orientate , able follow command complete require postoperative procedure , able tolerate fluid medication orally . Confinement study center patient per standard care , include surgery , entire 15-hour postdose evaluation period end-of-study evaluation . Children body weight less 20 kg dose single dose tapentadol 4 mg/mL OS child body weight 20 kg great dose single dose tapentadol 20 mg/mL OS .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Parent ( ) legal guardian ( ) patient sign informed consent document indicate understand purpose study , risk benefit procedure require study give permission child participate study Physical status rat I II American Society Anesthesiologists ( ASA ) rating scale Patient alert , orient , able follow command , able understand study requirement procedure , able communicate intelligibly health care provider ( take account his/her age ) As per investigator 's medical evaluation , patient able drink tolerate oral fluid medication Patient postoperative pain intensity score &gt; =4 McGrath Color Analog Scale ( CAS ) result schedule surgical procedure investigator 's clinical judgment ( ie , investigator judgment rely standard care rather McGrath CAS ) , patient pain level standard care follow surgical procedure ( reliably produce moderate severe pain ) require opioid treatment History seizure disorder epilepsy , serotonin syndrome , mild moderate traumatic brain injury , stroke , transient ischemic attack , brain neoplasm within 1 year screening , severe traumatic brain injury within 15 year screen , traumatic hypoxic brain injury result ongoing sequela suggest transient change consciousness Moderate severe renal hepatic impairment Requires concomitant use sedative , use surgery Has receive dextromethorphan within 2 day schedule study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Pain , Postoperative</keyword>
	<keyword>Postoperative Pain</keyword>
	<keyword>Tapentadol</keyword>
	<keyword>NUCYNTA</keyword>
	<keyword>CG5503</keyword>
	<keyword>R331333</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Postsurgical pain</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
</DOC>